The North America rare neurological disease treatment market is supported by advanced healthcare infrastructure, extensive clinical research, and increasing focus on early diagnosis and specialized care. Growing development of targeted and disease-modifying therapies, combined with greater awareness of rare neurological disorders and established treatment networks, is creating favorable...